Regional cerebral blood flow and cognitive function in patients with chronic liver disease.
paper
Cited
Public
Unavailable
- Authors
- O'Carroll, R E; Hayes, P C; Ebmeier, K P; Dougall, N; Murray, C; Best, J J; Bouchier, I A; Goodwin, G M
- Year
- 1991
- Journal
- Lancet (London, England)
- PMID
- 1674063
- DOI
- 10.1016/0140-6736(91)92920-w
Subtle impairments of cognitive function may be an important cause of occupational and psychosocial morbidity in patients with chronic liver disease. Correlation of structural brain abnormalities with cognitive deficits has yielded inconsistent results. 10 patients with cirrhotic liver disease were compared with 10 age, education, and intelligence matched control subjects. Neuropsychological assessment revealed significant overall cognitive impairments in cirrhotic patients compared with controls (p = 0.02). Regional cerebral blood flow was measured by single photon emission computed tomography (SPET or SPECT) and showed increased uptake of radiotracer in the right and left posterior parts of the basal ganglia and right occipital lobe, together with reduced uptake in the right anterior cingulate region. The degree of cognitive impairment was directly correlated with functional abnormalities in the basal ganglia and limbic cortex (p less than 0.05). Our results suggest that impaired cognitive status may be associated with abnormalities of regional brain function in patients with chronic liver disease. Since these deficits are clinically inapparent, our findings have important implications for identification and management of patients with chronic liver disease.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Neurocognitive deficits in male alcoholics: an ERP/sLORETA analysis of the N2 component in an equal probability Go/NoGo task. | 2012 | 22024409 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Regional cerebral blood flow in dogs with congenital extrahepatic portosystemic shunts before surgery and six months after successful closure. | Devriendt N et al. | — | 2023 | → |
| Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. | Zacharias HD et al. | — | 2023 | → |
| Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses. | Topiwala A et al. | — | 2022 | → |
| Altered cognitive control network is related to psychometric and biochemical profiles in covert hepatic encephalopathy. | Tsai CF et al. | — | 2019 | → |
| Impaired brain glucose metabolism in cirrhosis without overt hepatic encephalopathy: a retrospective 18F-FDG PET/CT study. | Zhang W et al. | — | 2019 | → |
| Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. | Zacharias HD et al. | — | 2019 | → |
| Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes. | Stader F et al. | — | 2019 | → |
| L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. | Goh ET et al. | — | 2018 | → |
| Symptoms of PBC - Pathophysiology and management. | Khanna A et al. | — | 2018 | → |
| Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial. | Romeiro FG et al. | — | 2018 | → |
| Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. | Goh ET et al. | — | 2017 | → |
| Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. | Goh ET et al. | — | 2017 | → |
| Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. | Chen Z et al. | — | 2017 | → |
| Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy. | Zheng G et al. | — | 2017 | → |
| Aquaporin 4 as a NH3 Channel. | Assentoft M et al. | — | 2016 | → |
| Clinical outcome prediction in aneurysmal subarachnoid hemorrhage - Alterations in brain-body interface. | Lo BW et al. | — | 2016 | → |
| Multimodal brain monitoring in fulminant hepatic failure. | Paschoal FM et al. | — | 2016 | → |
| Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. | Gluud LL et al. | — | 2016 | → |
| Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. | Gluud LL et al. | — | 2016 | → |
| Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients. | Sawhney R et al. | — | 2016 | → |
| Cirrhotic Multiorgan Syndrome. | Møller S et al. | — | 2015 | → |
| New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review. | Edula RG et al. | — | 2015 | → |
| Ammonia metabolism and hyperammonemic disorders. | Walker V | — | 2014 | → |
| Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. | Cordoba J | — | 2014 | → |
| Association of pre-operative brain pathology with post-operative delirium in a cohort of non-small cell lung cancer patients undergoing surgical resection. | Root JC et al. | — | 2013 | → |
| Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. | Zheng G et al. | — | 2013 | → |
| Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. | Ding S et al. | — | 2013 | → |
| Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study. | Zheng G et al. | — | 2013 | → |
| Brain imaging and hepatic encephalopathy. | McPhail MJ et al. | — | 2012 | → |
| Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. | Sunil HV et al. | — | 2012 | → |
| Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy. | Li T et al. | — | 2012 | → |
| Impaired small-world network efficiency and dynamic functional distribution in patients with cirrhosis. | Hsu TW et al. | — | 2012 | → |
| Neurocognitive deficits in male alcoholics: an ERP/sLORETA analysis of the N2 component in an equal probability Go/NoGo task. | Pandey AK et al. | — | 2012 | → |
| Current trends in the treatment of hepatic encephalopathy. | Al Sibae MR et al. | — | 2009 | → |
| Hepatic encephalopathy: pathophysiology and emerging therapies. | Sundaram V et al. | — | 2009 | → |
| Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization. | Borghammer P et al. | — | 2009 | → |
| Transport of AMPA receptors during long-term potentiation is impaired in rats with hepatic encephalopathy. | Monfort P et al. | — | 2009 | → |
| Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. | Boy C et al. | — | 2008 | → |
| Neuropsychological aspects of liver disease and its treatment. | O'Carroll RE | — | 2008 | → |
| Normalization in PET group comparison studies--the importance of a valid reference region. | Borghammer P et al. | — | 2008 | → |
| Quantitative cerebral water content mapping in hepatic encephalopathy. | Shah NJ et al. | — | 2008 | → |
| Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. | Sugimoto R et al. | — | 2008 | → |
| Blunted rostral anterior cingulate response during a simplified decoding task of negative emotional facial expressions in alcoholic patients. | Salloum JB et al. | — | 2007 | → |
| Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability. | Monfort P et al. | — | 2007 | → |
| Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure. | Rodrigo R et al. | — | 2007 | → |
| Minimal hepatic encephalopathy. | Stewart CA et al. | — | 2007 | → |
| NMDA receptors in hyperammonemia and hepatic encephalopathy. | Llansola M et al. | — | 2007 | → |
| Reduced frontal lobe activity in subjects with high impulsivity and alcoholism. | Chen AC et al. | — | 2007 | → |
| Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. | Pascoli D et al. | — | 2006 | → |
| Hepatic encephalopathy: a review of its pathophysiology and treatment. | Dbouk N et al. | — | 2006 | → |
| Suppression of early evoked gamma band response in male alcoholics during a visual oddball task. | Padmanabhapillai A et al. | — | 2006 | → |
| The role of neuroimaging in elucidating delirium pathophysiology. | Alsop DC et al. | — | 2006 | → |
| Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5. | Monfort P et al. | — | 2005 | → |
| Cognition in liver disease. | Collie A | — | 2005 | → |
| Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis. | Iwasa M et al. | — | 2005 | → |
| Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. | Yamamoto M et al. | — | 2005 | → |
| Memory impairment in patients with cirrhosis. | Bahceci F et al. | — | 2005 | → |
| Neuroimaging in hepatic encephalopathy. | Stewart CA et al. | — | 2005 | → |
| Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. | Erceg S et al. | — | 2005 | → |
| Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. | Erceg S et al. | — | 2005 | → |
| The utility of neurophysiological markers in the study of alcoholism. | Porjesz B et al. | — | 2005 | → |
| Characteristics of minimal hepatic encephalopathy. | Amodio P et al. | — | 2004 | → |
| Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis? | Burra P et al. | — | 2004 | → |
| Functional imaging of the brain in patients with liver cirrhosis. | Weissenborn K et al. | — | 2004 | → |
| Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. | Zafiris O et al. | — | 2004 | → |
| Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy. | Nakagawa Y et al. | — | 2004 | → |
| Subclinical hepatic encephalopathy: elusive 'gold standard'. | Kharbanda PS et al. | — | 2004 | → |
| [Hepatic encephalopathy]. | Schellinger PD et al. | — | 2003 | → |
| Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. | Yazgan Y et al. | — | 2003 | → |
| Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease. | Barbiroli B et al. | — | 2002 | → |
| Cerebral blood flow in hyperammonemia: heterogeneity and starling forces in capillaries. | Larsen FS | — | 2002 | → |
| Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy. | Spahr L et al. | — | 2002 | → |
| Frontal cerebral blood flow is impaired in patients with heart transplantation. | Burra P et al. | — | 2002 | → |
| Neurobiology of ammonia. | Felipo V et al. | — | 2002 | → |
| Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. | Kullmann F et al. | — | 2001 | → |
| Cerebral vascular resistance in hepatic insufficiency. | Kudo M | — | 2001 | → |
| Focal neurological signs in cirrhotic patients with episodes of hepatic encephalopathy. | Kyprianou A et al. | — | 2001 | → |
| Regional and systemic hemodynamic disturbances in cirrhosis. | Menon KV et al. | — | 2001 | → |
| Complications of cirrhosis III. Hepatic encephalopathy. | Butterworth RF | — | 2000 | → |
| Frontal P300 decrements, alcohol dependence, and antisocial personality disorder. | Costa L et al. | — | 2000 | → |
| 18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation. | Burra P et al. | — | 1999 | → |
| Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure. | Strauss GI et al. | — | 1999 | → |
| Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. | Philips BJ et al. | — | 1998 | → |
| Cerebral blood flow velocity in patients with subclinical portal-systemic encephalopathy. | Katz JJ et al. | — | 1998 | → |
| Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy. | Audet RM et al. | — | 1998 | → |
| Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. | Dam M et al. | — | 1998 | → |
| Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. | Geissler A et al. | — | 1997 | → |
| Hepatic encephalopathy and ascites. | Jalan R et al. | — | 1997 | → |
| Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. | Horsmans Y et al. | — | 1997 | → |
| Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy. | Gooday R et al. | — | 1995 | → |
| Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis. | Larsen FS et al. | — | 1995 | → |
| Clinical evaluation of liver disease. | Simpson KJ et al. | — | 1995 | → |
| Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. | Butterworth RF et al. | — | 1995 | → |
| Psychological assessment in liver disease. | Masterton G et al. | — | 1995 | → |
| Visual attention orienting in liver cirrhosis without overt hepatic encephalopathy. | Amodio P et al. | — | 1995 | → |
| PASAT performance and the pattern of uptake of 99mTc-exametazime in brain estimated with single photon emission tomography. | Deary IJ et al. | — | 1994 | → |
| The neuropathogenesis of delirium. A need to focus our research. | Trzepacz PT | — | 1994 | → |
| A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia. | Riddle W et al. | — | 1993 | → |
| Extrahepatic manifestations of alcoholic liver disease. | Hayes PC | — | 1993 | → |
| Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. | Lockwood AH et al. | — | 1993 | → |
| Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. | Mousseau DD et al. | — | 1993 | → |
| Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. | Kulisevsky J et al. | — | 1992 | → |
| Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. | Austin MP et al. | — | 1992 | → |